Navigation Links
Combo Therapy may Be Highly Beneficial in Asthma Control

A new study has found that combination asthma therapy, SYMBICORT leads to significant improvements in health-related quality of life (HRQL) and greater patient-reported satisfaction with asthma treatment, versus its monocomponents (budesonide or formoterol or placebo).

SYMBICORT is a recently approved, combination therapy indicated for the long-term maintenance treatment of asthma in patients 12 years of age and older. SYMBICORT does not replace fast-acting inhalers and should not be used to treat acute symptoms of asthma.

SYMBICORT is a combination of two proven asthma medications budesonide, an inhaled corticosteroid (ICS), and formoterol, a rapid and long-acting beta agonist (LABA).

As part of the 12-week, randomised, double-blind, placebo-controlled, multicenter study, researchers measured HRQL in 553 patients with moderate-to-severe persistent asthma treated with one of five SYMBICORT therapies.

The patients were subjected to two inhalations with SYMBICORT in one pressurised meter-dose inhaler (pMDI) 160/4.5 micrograms (mcg); budesonide pMDI 160 mcg; formoterol via dry-powder inhaler (DPI) 4.5 mcg; budesonide pMDI 160 mcg + formoterol DPI 4.5 mcg in separate inhalers; or placebo, each bid.

HRQL was assessed using the standardised Asthma Quality of Life Questionnaire [AQLQ(S)], a validated survey that measures how asthma affects a person's daily activities, emotional functioning, and symptoms and using patient and physician global assessments.

The study also measured satisfaction to treatment in 390 patients with mild-to-moderate asthma previously treated with inhaled corticosteroids. Patients were randomised to receive treatment with two inhalations with SYMBICORT 80/4.5 mcg, budesonide pMDI 80 mcg, formoterol DPI 4.5 mcg, or placebo, each bid.

Patient satisfaction was assessed using three indices of the Patient Satisfaction with Asthma Medication (PSAM) questi
'"/>




Page: 1 2

Related medicine news :

1. Drug Combo Works Better for children with ADHD, Tics
2. Scanning Combo Helps Detect Lung Cancer
3. Relief From Asthma With New Combo Therapy
4. Calcium-Vitamin D Combo For Reduced Fracture Risk
5. Drug Combo Improves Performance Of Multiple Sclerosis Drug
6. Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety?
7. HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy
8. The Combo Treatment Is Effective to Treat Type 1 Diabetes in Mice
9. Doomed Duo: Obesity and Type 2 Diabetes Combo, Can Nip Life in the Bud
10. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
11. Fuzeon and MK-0518 Combo Holds Promise For HIV
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Combo Therapy may Highly Beneficial Asthma Control

(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative naturopathic ... to bring about self-renewal. A 30 day detox is ... cleaning house. According to Dr. Cutler, expert in ... environmental toxins like heavy metals, people’s food now becoming ... levels, we all have a level of toxic burden. ...
(Date:3/2/2015)... A cocaine snorting Oscar statue in ... nip slip or scathing scuffle. A new take on ... streets of Hollywood as Paper Jesus’ rendition of the ... substance abuse in Hollywood. The Oscar statue is depicted ... stance on the travails of drug addiction in Hollywood. ...
(Date:3/2/2015)... Clearwater, FL (PRWEB) March 02, 2015 ... comply with Title VI of the Civil Rights Act, ... (LEP) and hearing loss are bringing light to the ... Bureau statistics reveal that nearly 1 in 20 U.S. ... 1 in 10 in some major cities.(1) Stratus ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In ... in Construction Week (March 1-7, sponsored by the National ... Women’s History Month, Robins & Morton is recognizing several ... and the construction industry as a whole. From the ... of roles in between, each woman has a story ...
(Date:3/2/2015)... March 02, 2015 Over the last ... among leading vendors seeking to expand their geographic presence ... is expected to reach $6.2 billion by 2019 at ... America including the U.S. and Canada and a major ... However developing regions such as Asia-Pacific including China and ...
Breaking Medicine News(10 mins):Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:Robins & Morton Recognizes Women In Construction 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3
... Aug. 28, 2007 Dietary restrictions or other ... transplants more effective, UT Southwestern Medical Center researchers report. ... pancreatic islet cells transplanted into the liver fail not ... overexposure to toxic fats that are synthesized by the ...
... be available an open question, researcher says , , MONDAY, ... cardiac arrest while on school grounds, it makes the evening ... property is rare, and most of the victims are adults, ... service calls in the Seattle area, researchers found that faculty ...
... spend part of the Labor Day weekend complaining about their ... their jobs, a new University of Chicago study shows. ... with workers over 65 among the most satisfied. The ... 1972 and 2006 said they were satisfied at their jobs, ...
... A landmark study by University of Western Sydney researchers ... suffer fewer fractures and enjoy a better quality of ... calcium or calcium and vitamin D supplements, conducted by ... been published this week in the prestigious international medical ...
... survival, functioning may have been solved in rat experiments ... rats show that human embryonic stem cells can repair ... progression of heart failure. , Using stem cells to ... so far it has been fraught with problems. ...
... ears: Be sensible to avoid skin irritation , FRIDAY, Aug. ... that it,s almost like an addiction. , "For many people, it ... they,ve become so used to their lips having more moisture content ... at Baylor Medical Center in Garland, Texas, said in a prepared ...
Cached Medicine News:Health News:Circulating fats kill transplanted pancreas cells, study shows 2Health News:Heart Attacks at School Involve More Adults Than Kids 2Health News:Heart Attacks at School Involve More Adults Than Kids 3Health News:Despite grumbling, most Americans say they are happy at work 2Health News:International study strengthens case for daily calcium pill 2Health News:Embryonic Stem Cells Repair Human Heart 2Health News:Embryonic Stem Cells Repair Human Heart 3
(Date:3/2/2015)... -- DURECT Corporation (Nasdaq: DRRX ) announced today ... 2014. Total revenues were $4.3 million for the three ... months ended December 31, 2013.  Net loss was $5.9 ... as compared to a net loss of $5.1 million ... million and net loss was $22.1 million for the ...
(Date:3/2/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... year ended December 31, 2014. Financial highlights for the fourth ... of $5.3 million, or $0.04 per share. This compares to ... million, or $0.19 per share, for the fourth quarter of ... of $75.3 million and a net loss of $68.4 million, ...
(Date:3/2/2015)... -- Vivex Biomedical, Inc., a leading processor of human tissue, ... that it hired Lou Barnes as President ... Biomedical formed UMTB Biomedical as a wholly-owned subsidiary to ... November 2014. UMTB is the oldest tissue bank in ... year veteran of the tissue banking industry, having most ...
Breaking Medicine Technology:DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 2DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 3DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 4DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 5DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 6DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 7DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 8DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 9DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 10DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 11DURECT Corporation Announces Fourth Quarter 2014 Financial Results and Update of Programs 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3
... June 20, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... subsidiary, Watson Laboratories, Inc. – Florida, filed an ... Food and Drug Administration (FDA) seeking approval to ... product is a generic version of GlaxoSmithKline,s AVODART(R), ...
... Findings from three studies conducted by the U.S. Food ... conveyed and displayed in printed drug advertising affects consumer ... ) The studies, designed by experts ... (DDMAC) in the Center for Drug Evaluation and Research, ...
Cached Medicine Technology:Watson Confirms AVODART(R) Patent Challenge 2FDA Examines Ways to Improve Consumer Understanding of Prescription Drug Ads 2FDA Examines Ways to Improve Consumer Understanding of Prescription Drug Ads 3